Acelyrin has punted the autoimmune drug prospect izokibep back to Affibody, complet | Acelyrin has punted the autoimmune drug prospect izokibep back to Affibody, completing a retreat from its former ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback